Three companies reporting earnings next week have historically surpassed analyst estimates and seen their shares rise in response.
Category: Uncategorized
This biotech stock is an ‘oncology powerhouse’ with 40% upside, says Truist Securities
The firm’s 12-month price target on the Nasdaq-traded shares of the German company is $172.
Insurance stocks sell off sharply as potential losses tied to LA wildfires increase
AllState, Chubb and Travelers are the most exposed carriers to insured losses in the wildfires, according to JPMorgan.
Here are Friday’s biggest analyst calls: Nvidia, Netflix, Tesla, Nike, Sunrun, Amazon, Pinterest & more
Here are Friday’s biggest calls on Wall Street.
Citi upgrades McDonald’s to buy as fast-food giant leans into value pivot
Shares of McDonald’s could rise 16% after a lackluster 2024, Citi said.
UBS upgrades this solar stock to buy, calls it a ‘clear market leader’
A second Trump administration might not necessarily present headwinds for the solar sector as investors have feared, according to UBS.
Piper Sandler upgrades Nike, says a path to recovery is emerging
Piper Sandler expects Nike to return to healthy and profitable and sales growth by the third quarter of 2026.
Goldman Sachs downgrades Advanced Micro Devices as competitive pressures intensify
Shares of Advanced Micro Devices will trade range-bound until investors gain renewed optimism about the company’s future growth trajectory, Goldman Sachs wrote.
Gold is poised for a new bullish phase, according to the charts. Here are the levels to watch
David Keller breaks down the charts in the SPDR Gold Shares and Kinross.
Watch these stocks that could capitalize on a private market boom
Investors are hoping to tap into a growing trend in financial services — the migration of capital into private markets from public.